Results 181 to 190 of about 97,810 (274)

Association of Tralokinumab and Adalimumab: Good Tolerance and Efficacy in a Case of Severe Atopic Dermatitis and Juvenile Idiopathic Arthritis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Atopic dermatitis is a chronic inflammatory and pruritic skin disease. The combination of tralokinumab with adalimumab in the treatment of inflammatory diseases had not yet been documented. It appears promising for treating severe atopic dermatitis in patients with juvenile idiopathic arthritis, offering significant improvement in skin ...
F. Rakotonandrasana   +3 more
wiley   +1 more source

Comparison of flares in 85 patients with SLE who maintained, discontinued or reduced dose of hydroxychloroquine during a prospective study of ophthalmological screening for retinopathy (PERFOCTAPS Study). [PDF]

open access: yesLupus Sci Med
Marques Dias JI   +11 more
europepmc   +1 more source

Access to Emollients in Atopic Dermatitis

open access: yes
JEADV Clinical Practice, EarlyView.
Stephanie‐Lynn Ryan   +2 more
wiley   +1 more source

Achieving Brazil's Deforestation Target Will Reduce Fire and Deliver Air Quality and Public Health Benefits

open access: yesEarth's Future, Volume 10, Issue 12, December 2022., 2022
Abstract Climate, deforestation, and forest fires are closely coupled in the Amazon, but models of fire that include these interactions are lacking. We trained machine learning models on temperature, rainfall, deforestation, land‐use, and fire data to show that spatial and temporal patterns of fire in the Amazon are strongly modified by deforestation ...
Edward W. Butt   +6 more
wiley   +1 more source

Uptake and safety of pneumococcal vaccination in adults with immune-mediated inflammatory diseases: a UK wide observational study. [PDF]

open access: yesRheumatology (Oxford)
Nakafero G   +5 more
europepmc   +1 more source

Patient's Perspective on the Impact of Psoriasis on Their Quality of Life After 1 Year of Tildrakizumab Treatment: Despite Clinical Improvement, Persistence of a Potential Mental Cicatricial Memory of the Disease

open access: yesJEADV Clinical Practice, EarlyView.
In this real‐life study, tildrakizumab confirmed its efficacy in treating moderate‐to‐severe psoriasis, including challenging areas. Despite good disease control, some patients expressed dissatisfaction, highlighting the cumulative mental burden of delayed effective treatment and underscoring the mental scars left by psoriasis, persisting even after ...
Ziad Reguiai   +16 more
wiley   +1 more source

Mild to moderate ulcerative colitis: Call me by my name

open access: yes, 2022
United European Gastroenterology Journal, Volume 10, Issue 9, Page 919-920, November 2022.
Iago Rodríguez‐Lago   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy